Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$160.2 - $186.42 $463,458 - $539,313
-2,893 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$150.19 - $173.5 $91,615 - $105,835
-610 Reduced 17.41%
2,893 $476,000
Q4 2020

Feb 10, 2021

BUY
$140.71 - $165.05 $57,409 - $67,340
408 Added 13.18%
3,503 $578,000
Q3 2020

Nov 12, 2020

BUY
$105.46 - $144.13 $326,398 - $446,082
3,095 New
3,095 $441,000
Q2 2020

Aug 10, 2020

SELL
$95.68 - $121.88 $14,160 - $18,038
-148 Closed
0 $0
Q1 2020

Apr 20, 2020

SELL
$87.74 - $152.74 $54,837 - $95,462
-625 Reduced 80.85%
148 $15,000
Q1 2018

May 08, 2018

BUY
$135.59 - $157.16 $5,694 - $6,600
42 Added 5.75%
773 $117,000
Q3 2017

Oct 19, 2017

BUY
$142.62 - $155.6 $104,255 - $113,743
731
731 $107,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ls Investment Advisors, LLC Portfolio

Follow Ls Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.